High Intensity Focused Ultrasound (HIFU) Therapy Market Key drivers, Business

Posted by vinit sawant on March 18th, 2021

According to a recent study report published by Market Research Future (MRFR), the global high intensity focused ultrasound (HIFU) therapy market will garner significant accruals by 2023, registering a CAGR of 7.8% throughout the forecast period (2017-2023).

HIFU technology is also extensively used in the development of cosmetic medicines. Moreover, HIFU therapy is broadly used in the field of interventional oncology due to its sharp treatment margins and low complication rates.

High Intensity Focused Ultrasound (HIFU) therapy is essentially indicated for patients with different kinds of tremors and cancer patients. This technique is based on ultrasound and helps in pinpointing the exact cell that is involved in the growth of the tumor.

This non-invasive therapy demonstrates great potential in the areas such as the tumor ablation, hemostasis, thrombolysis as well as targeted drug/gene delivery. Owing to the non-invasive nature of HIFU therapy it is widely preferred among patients undergoing treatments of various chronic diseases such as prostate cancer, uterine fibroids, and neurological disorders.

The HIFU therapy market in the European region accounts for the second-largest market, globally. Factors such as the increasing demand for painless therapies among the rising number of cancer and other chronic diseases patients predominantly drive the growth of the regional market.

Owing to the augmenting demand for minimally invasive therapy to treat the chronic diseases such as cancer, the HIFU therapy market in the North American region is expected to grow at a significant rate of CAGR throughout the forecast period, creating a large revenue pocket by 2023.

Like it? Share it!


vinit sawant

About the Author

vinit sawant
Joined: July 4th, 2019
Articles Posted: 359

More by this author